G
eneralized anxiety disorder (GAD) is one of the most
common psychiatric disorders encountered in the
primary care setting. Lifetime prevalence of GAD
is approximately 5% in the U.S. adult population [1,2]; prevalence in the primary care setting has been estimated at 8%
[3,4]. GAD usually has a chronic course that is associated with
significant psychosocial impairment, disability, decreased
quality of life, and increased use of health care resources
[5–8]. In spite of the high prevalence of GAD, it is frequently overlooked and undertreated. Only 30% of GAD patients
who present to primary care are diagnosed [7]. Increasing
the awareness of GAD among patients and physicians may
lead to improved recognition and appropriate intervention,
thereby reducing disability and improving quality of life